skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Reported CD4+ T-Lymphocyte Results for Adults and Adolescents with HIV/AIDS—33 States, 2005
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 3. Median results of the first CD4 test performed within 12 months after HIV diagnosis among adults and adolescents with HIV/AIDS, by year of diagnosis and selected characteristics, 2001–2003—33 states with confidential name-based HIV infection reporting
spacer
spacer
View PDF PDF icon

  2001 2002 2003
Median CD4 counta 25%–75% Total No. Median CD4 counta 25%–75% Total No. Median CD4 counta 25%–75% Total No.
Sex
Male 168 48–380 15,734 165 47–383 15,895 164 48–365 16,083
Female 187 63–412 6,086 187 68–418 5,747 180 59–398 5,849
Age as of end of year (yrs)
13–14 197 37–528 26 273 150–395 23 338 134–588 33
15–24 352 176–544 1,812 328 163–510 1,717 326 153–506 1,942
25–34 197 63–429 5,891 192 62–436 5,673 190 65–417 5,509
35–44 160 44–364 8,141 162 46–374 8,210 153 45–349 8,232
45–54 147 44–316 4,272 140 41–325 4,348 134 36–312 4,471
55–64 131 38–288 1,289 122 34–262 1,303 131 41–275 1,325
≥65 116 32–209 390 107 35–239 369 119 41–235 421
Transmission category
Male adult or adolescent
Male-to-male sexual contact 182 55–407 9,170 180 56–415 9,565 181 57–397 9,806
Injection drug use 151 42–326 2,865 140 36–309 2,689 138 36–312 2,577
Male-to-male sexual contact and injection drug use 200 60–448 916 195 62–468 921 182 55–414 888
Heterosexual contactb 134 33–303 2,662 123 32–285 2,600 127 32–271 2,695
Otherc 106 31–197 121 122 40–323 120 98 25–214 117
Female adult or adolescent
Injection drug use 182 66–395 1,440 190 68–441 1,290 176 64–411 1,277
Heterosexual contactb 192 63–419 4,527 187 68–416 4,347 182 59–399 4,450
Otherc 126 31–268 119 150 46–252 110 126 35–266 121
Race/ethnicity
White, not Hispanic 217 74–468 6,695 218 78–478 6,939 199 72–444 7,042
Black, not Hispanic 164 40–362 10,937 156 41–348 10,514 154 38–347 10,665
Hispanic 158 48–324 3,812 151 44–339 3,791 151 48–313 3,802
Asian/Pacific Islander 167 46–337 142 170 48–360 162 179 69–389 223
American Indian/Alaska Native 198 72–434 114 299 90–467 127 186 48–385 109
Unknown 272 86–514 120 171 39–362 109 189 68–440 91
Totald 175 50–389 21,820 170 50–393 21,642 167 50–374 21,932
Note. These numbers do not represent actual cases in persons with a diagnosis of HIV infection or AIDS. Rather, these numbers are point estimates of case counts that have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates have not been adjusted for incomplete reporting.
Since 2000, the following states have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, and Wyoming. Since July 1997, Florida has had confidential name-based HIV infection reporting for new diagnoses only.
a When only CD4 percentage was available, a CD4 count was interpreted.
b With person at high risk or with a diagnosis of HIV infection or AIDS.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or identified.
d Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Last Modified: March 14, 2006
Last Reviewed: March 14, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services